264 related articles for article (PubMed ID: 30230387)
1. Synthesis and structure-activity relationships of 2- and/or 4-halogenated 13β- and 13α-estrone derivatives as enzyme inhibitors of estrogen biosynthesis.
Bacsa I; Herman BE; Jójárt R; Herman KS; Wölfling J; Schneider G; Varga M; Tömböly C; Rižner TL; Szécsi M; Mernyák E
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1271-1282. PubMed ID: 30230387
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of A-ring halogenated 13α-estrone derivatives as potential 17β-HSD1 inhibitors.
Bacsa I; Jójárt R; Schneider G; Wölfling J; Maróti P; Herman BE; Szécsi M; Mernyák E
Steroids; 2015 Dec; 104():230-6. PubMed ID: 26476182
[TBL] [Abstract][Full Text] [Related]
3. Comparative investigation of the in vitro inhibitory potencies of 13-epimeric estrones and D-secoestrones towards 17β-hydroxysteroid dehydrogenase type 1.
Herman BE; Szabó J; Bacsa I; Wölfling J; Schneider G; Bálint M; Hetényi C; Mernyák E; Szécsi M
J Enzyme Inhib Med Chem; 2016; 31(sup3):61-69. PubMed ID: 27424610
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro pharmacological evaluation of N-[(1-benzyl-1,2,3-triazol-4-yl)methyl]-carboxamides on d-secoestrone scaffolds.
Szabó J; Bacsa I; Wölfling J; Schneider G; Zupkó I; Varga M; Herman BE; Kalmár L; Szécsi M; Mernyák E
J Enzyme Inhib Med Chem; 2016 Aug; 31(4):574-9. PubMed ID: 26360618
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of substituted 15β-alkoxy estrone derivatives and their cofactor-dependent inhibitory effect on 17β-HSD1.
Herman BE; Kiss A; Wölfling J; Mernyák E; Szécsi M; Schneider G
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1271-1286. PubMed ID: 31307240
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.
Lawrence Woo LW; Leblond B; Purohit A; Potter BV
Bioorg Med Chem; 2012 Apr; 20(8):2506-19. PubMed ID: 22455789
[TBL] [Abstract][Full Text] [Related]
7. Estrone C15 derivatives--a new class of 17beta-hydroxysteroid dehydrogenase type 1 inhibitors.
Messinger J; Husen B; Koskimies P; Hirvelä L; Kallio L; Saarenketo P; Thole H
Mol Cell Endocrinol; 2009 Mar; 301(1-2):216-24. PubMed ID: 19014997
[TBL] [Abstract][Full Text] [Related]
8. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
9. Steroidal ferrocenes as potential enzyme inhibitors of the estrogen biosynthesis.
Herman BE; Gardi J; Julesz J; Tömböly C; Szánti-Pintér E; Fehér K; Skoda-Földes R; Szécsi M
Biol Futur; 2020 Sep; 71(3):249-264. PubMed ID: 34554507
[TBL] [Abstract][Full Text] [Related]
10. Estrogen formation in endometrial and cervix cancer cell lines: involvement of aromatase, steroid sulfatase and 17beta-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12).
Fournier MA; Poirier D
Mol Cell Endocrinol; 2009 Mar; 301(1-2):142-5. PubMed ID: 18817841
[TBL] [Abstract][Full Text] [Related]
11. Pd-Catalyzed microwave-assisted synthesis of phosphonated 13α-estrones as potential OATP2B1, 17β-HSD1 and/or STS inhibitors.
Jójárt R; Pécsy S; Keglevich G; Szécsi M; Rigó R; Özvegy-Laczka C; Kecskeméti G; Mernyák E
Beilstein J Org Chem; 2018; 14():2838-2845. PubMed ID: 30498534
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Biological Evaluation and Docking Studies of 13-Epimeric 10-fluoro- and 10-Chloroestra-1,4-dien-3-ones as Potential Aromatase Inhibitors.
Jójárt R; Traj P; Kovács É; Horváth Á; Schneider G; Szécsi M; Pál A; Paragi G; Mernyák E
Molecules; 2019 May; 24(9):. PubMed ID: 31072017
[TBL] [Abstract][Full Text] [Related]
13. Novel, potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
Allan GM; Bubert C; Vicker N; Smith A; Tutill HJ; Purohit A; Reed MJ; Potter BV
Mol Cell Endocrinol; 2006 Mar; 248(1-2):204-7. PubMed ID: 16337736
[TBL] [Abstract][Full Text] [Related]
14. Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential.
Thomas MP; Potter BV
J Steroid Biochem Mol Biol; 2015 Sep; 153():160-9. PubMed ID: 25843211
[TBL] [Abstract][Full Text] [Related]
15. Structure-based design, synthesis and in vitro characterization of potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitors based on 2-substitutions of estrone and D-homo-estrone.
Möller G; Deluca D; Gege C; Rosinus A; Kowalik D; Peters O; Droescher P; Elger W; Adamski J; Hillisch A
Bioorg Med Chem Lett; 2009 Dec; 19(23):6740-4. PubMed ID: 19836949
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives.
Sinreih M; Jójárt R; Kele Z; Büdefeld T; Paragi G; Mernyák E; Rižner TL
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1500-1508. PubMed ID: 34227437
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 16β-derivatives of 3-(2-bromoethyl)-estra-1,3,5(10)-trien-17β-ol as inhibitors of 17β-HSD1 and/or steroid sulfatase for the treatment of estrogen-dependent diseases.
Lespérance M; Roy J; Djiemeny Ngueta A; Maltais R; Poirier D
Steroids; 2021 Aug; 172():108856. PubMed ID: 33945801
[TBL] [Abstract][Full Text] [Related]
18. The difluoromethylene group as a replacement for the labile oxygen in steroid sulfates: a new approach to steroid sulfatase inhibitors.
Lapierre J; Ahmed V; Chen MJ; Ispahany M; Guillemette JG; Taylor SD
Bioorg Med Chem Lett; 2004 Jan; 14(1):151-5. PubMed ID: 14684318
[TBL] [Abstract][Full Text] [Related]
19. Chemical synthesis, characterisation and biological evaluation of furanic-estradiol derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 1.
Farhane S; Laplante Y; Poirier D
Med Chem; 2011 Mar; 7(2):80-91. PubMed ID: 21222612
[TBL] [Abstract][Full Text] [Related]
20. Regulation of steroid sulphatase and oestradiol 17 beta-hydroxysteroid dehydrogenase in breast cancer.
Purohit A; Singh A; Reed MJ
Biochem Soc Trans; 1999 Feb; 27(2):323-7. PubMed ID: 10093756
[No Abstract] [Full Text] [Related]
[Next] [New Search]